BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 21985044)

  • 21. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience.
    Sachs UJ; Link E; Hofmann C; Wasel W; Bein G
    Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfusion-related acute lung injury (TRALI): a review of investigations by the National Tissue Typing Laboratory of cases reported in New Zealand since June 2004.
    Dunn P; Dinesh D
    N Z Med J; 2008 Jun; 121(1276):42-7. PubMed ID: 18574508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfusion related acute lung injury (TRALI) caused by red blood cell transfusion involving residual plasma anti-HLA antibodies: a report on two cases and general considerations.
    Odent-Malaure H; Quainon F; Ruyer-Dumontier P; Ducroz S; Verdier P; Voitellier E; Raynal MF; Fromont P; Muller JY; Rebibo D; Absi L; Garraud O
    Clin Dev Immunol; 2005 Dec; 12(4):243-8. PubMed ID: 16584109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States.
    Kleinman S; Grossman B; Kopko P
    Transfusion; 2010 Jun; 50(6):1312-21. PubMed ID: 20456690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of leucocyte antibodies in the Dutch donor population.
    Middelburg RA; Porcelijn L; Lardy N; Briët E; Vrielink H
    Vox Sang; 2011 Apr; 100(3):327-35. PubMed ID: 20946548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfusion-related acute lung injury (TRALI): a case report and literature review.
    Donelan KJ; Anderson KA
    S D Med; 2011 Mar; 64(3):85-8. PubMed ID: 21473518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of fresh-frozen plasma from male-only donors versus mixed-sex donors on postoperative respiratory function in surgical patients: a prospective case-controlled study.
    Nakazawa H; Ohnishi H; Okazaki H; Hashimoto S; Hotta H; Watanabe T; Ohkawa R; Yatomi Y; Nakajima K; Iwao Y; Takamoto S; Shimizu M; Iijima T
    Transfusion; 2009 Nov; 49(11):2434-41. PubMed ID: 19624605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transfusion therapy and acute lung injury.
    Sokolovic M; Pastores SM
    Expert Rev Respir Med; 2010 Jun; 4(3):387-93. PubMed ID: 20524921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The practice of reporting transfusion-related acute lung injury: a national survey among clinical and preclinical disciplines.
    Vlaar AP; Wortel K; Binnekade JM; van Oers MH; Beckers E; Gajic O; Schultz MJ; Juffermans NP
    Transfusion; 2010 Feb; 50(2):443-51. PubMed ID: 19804567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
    Reil A; Keller-Stanislawski B; Günay S; Bux J
    Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfusion-related acute lung injury and leucocyte-reacting antibodies.
    Zupanska B; Uhrynowska M; Michur H; Maslanka K; Zajko M
    Vox Sang; 2007 Jul; 93(1):70-7. PubMed ID: 17547568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfusion-related acute lung injury: Current understanding and preventive strategies.
    Vlaar AP
    Transfus Clin Biol; 2012 Jun; 19(3):117-24. PubMed ID: 22682310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transfusion-related acute lung injury: a preventable syndrome?
    Müller MC; Juffermans NP
    Expert Rev Hematol; 2012 Feb; 5(1):97-106. PubMed ID: 22272709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mac1+/Gr1+ cells contribute to transfusion-related acute lung injury.
    Hu XB; Yin DD; Chen YZ; Yang HF; Zhang XQ
    Transfus Apher Sci; 2013 Dec; 49(3):474-81. PubMed ID: 23548440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary pathology of rapidly fatal transfusion-related acute lung injury reveals minimal evidence of diffuse alveolar damage or alveolar granulocyte infiltration.
    Danielson C; Benjamin RJ; Mangano MM; Mills CJ; Waxman DA
    Transfusion; 2008 Nov; 48(11):2401-8. PubMed ID: 18673344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relation between aged blood products and onset of transfusion-related acute lung injury. A review of pre-clinical data.
    Vlaar AP; Straat M; Juffermans NP
    Clin Lab; 2011; 57(3-4):267-72. PubMed ID: 21500739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation.
    Nicolle AL; Chapman CE; Carter V; Wallis JP
    Transfus Med; 2004 Jun; 14(3):225-30. PubMed ID: 15180814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Residual plasma in red blood cells and transfusion-related acute lung injury.
    Weber LL; Roberts LD; Sweeney JD
    Transfusion; 2014 Oct; 54(10):2425-30. PubMed ID: 24762170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A solution to the problem of studying blood donor-related risk factors when patients have received multiple transfusions.
    Middelburg RA; le Cessie S; Briët E; Vandenbroucke JP; van der Bom JG
    Transfusion; 2010 Sep; 50(9):1959-66. PubMed ID: 20456711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DR antibodies in transfusion-related acute lung injury (TRALI): a case report.
    Muro M; Rivera J; Botella C; Campillo JA; Ferrer F; Alvarez-López MR
    Transfus Apher Sci; 2008 Jun; 38(3):209-12. PubMed ID: 18462996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.